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In general, rare thyroid diseases can be divided into neo-
plastic and non-neoplastic.
Neoplastic rare thyroid diseases include the following:
1. primary thyroid lymphoma (1-5% all malignant neo-
plasms of the thyroid; 2:1 000 000 per year);
2. metastases to the thyroid gland (2-3% malignant
thyroid neoplasms; 0.5-2.8% in autopsy) from various
primary cancers such as breast carcinoma, renal carci-
noma, colon carcinoma, melanoma and others;
3. others (ie: sarcoma).
On the contrary, non-neoplastic rare thyroid diseases
include the following:
1. congenital defects of thyroxine binding proteins, parti-
cularly partial and total congenital TBG deficiency (1:5
000), congenital TBG excess (1: 25 000) (both caused by
TBG gene mutations) and familial dysalbuminemic
hyperthyroxinemia (1:25 000, more frequent in some popu-
lations, such as the Spanish and Portuguese);
2. congenital resistance to thyroid hormones (with
frequency about 1:40 000) as a result of THRB gene
mutations;
3. rare cases of congenital thyroid hormones biosynth-
esis defects, for instance: Pendred syndrome (with fre-
quency of 7.5-10:100 000) resulting from PDS gene
mutations, total iodide organification defects (1:66 000;
TPO and THOX2 gene mutations);
4. congenital defects of the thyroid gland development,
which constitute about 85-90% causes of primary congeni-
tal hypothyroidism. About 2% of these are associated with
the presence of other nonthyroid congenital anomalies
and are caused by genetic mutations: for example, in the
PAX, TTF1, TTF2, GNAS 1 genes;
5. congenital nonautoimmune hyperthyroidism as a
result of TSH receptor gene mutation (TSHR) (until now
55 various mutations and over a dozen cases of de novo
germinal mutations have been described);
6. hyperthyroidism associated with McCune-Albright
syndrome (in about 30% of patients with this syndrome;
McCune-Albright syndrome frequency of occurrence is
estimated - 1:10 000-1:1 000 000; background - mutation
in the GNAS 1 gene);
7. an association of the thyroid autonomous nodule and
Graves’ disease (4.1%), and the thyroid cancer and Graves’
disease (1.1%-6.5%).
The latest data on the etiopathogenesis of rare thyroid
diseases, diagnostic criteria and possibilities for their
treatment will be discussed. In addition, information
obtained from PUBMED database concerning patients
with rare thyroid diseases detected in the Polish popula-
tion, particularly the data on molecular-genetic results,
will be presented.
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